𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A sequential double-blind controlled study of moclobemide and mianserin in elderly depressed patients

✍ Scribed by John Tiller; Dr Kay Maguire; Brian Davies


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
498 KB
Volume
5
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Moclobemide was compared with mianserin in a double-blind controlled study in elderly depressed patients. Sequential analysis of 1 1 pairs of patients found no significant difference between the drugs at the week 8 analysis. Unpaired comparison of the 26 patients completing four weeks' treatment also showed no significant difference between the two drugs. Both drugs significantly reduced Hamilton and Carroll depression rating scores. A separate analysis of the 20 patients completing eight weeks' treatment showed that both drugs produced significant decreases in Hamilton and Carroll depression ratings with no significant difference between the two drugs for depression scores at either week 4 or 8. Side-effects were minimal, with the most severe emergent side-effects for moclobemide being sleep disturbance, blurred vision and dry mouth. KEY worn-Moclobemide, mianserin, elderly, depression.


πŸ“œ SIMILAR VOLUMES


Sulpiride and placebo in depressed elder
✍ Sirkka-Liisa KivelΓ€; Erkki LehtomΓ€ki πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 423 KB πŸ‘ 1 views

In a controlled double-blind study, sulpiride 10G200mg daily or placebo was administered over a five-month period to 22 and 24 depressive elderly outpatients. The majority of the patinets in both groups were diagnosed as suffering from relatively mild degrees of depression, i.e. from dysthymic disor

Zuclopenthixol and thioridazine in the t
✍ A. Harenko; I. Alanen; S. Elovaara; S. GinstrΓΆm; U. Hagert; M. SavijΓ€rvi; A. Yli πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 441 KB πŸ‘ 1 views

A four-week double-blind study of zuclopenthixol and thioridazine in 64 elderly patients presenting with hostility or restlessness has been carried out in five Finnish mental hospitals. The ages of the patients in the two groups ranged from 64 to 97 years. The initial daily dose was 2-6 mg zuclopent

Randomized double-blind placebo-controll
✍ Gregory H. Pelton; Oliver L. Harper; Matthias H. Tabert; Harold A. Sackeim; Niko πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views

## Abstract ## Objective To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment. ## Methods Twenty‐three elderly (>50 years old) depressed, cognitively impaired (DEP‐CI) patients participated in a pilot study. W

Venlafaxine versus nortriptyline in the
✍ Rob M. Kok; Willem A. Nolen; Thea J. Heeren πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 1 views

## Abstract ## Background The majority of the trials in the elderly are outpatient trials which excluded psychotic patients and patients with common comorbid physical disorders. Consequently information is lacking about the more complex cases of elderly depressed patients, as found in inpatient wa

A randomised, double-blind comparison of
✍ Ingvar Karlsson; Jan Godderis; Carlos Augusto De MendonΓ§a Lima; Harald Nygaard; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 327 KB πŸ‘ 2 views

Depression is the most common psychiatric disorder among the elderly and in old age may interact with emotional and cognitive functioning. Depression in old age has been shown to be associated with degenerative changes in the brain. It is, therefore, important that in this patient population antidep